How do I launch a peptide therapy brand?
A peptide therapy brand launches the same way as any prescription telehealth brand, with one extra step at the start: confirming that every peptide on the menu can be legally prescribed and compounded. Prescription peptides need a licensed provider to evaluate each patient and a licensed pharmacy to fill the order, usually a 503A compounding pharmacy (a state-licensed pharmacy that prepares medication for an individual patient's prescription), and injectable peptides need cold-chain shipping. FDA's rules on which peptides a pharmacy may compound are changing through 2026, so the menu has to be checked against FDA's current lists before launch and again each time they move. The founder does not need a medical license: the business owns the brand, and a clinician-owned practice makes the medical decisions. On Tessic Health, longevity and peptide programs run on the same providers licensed in all 50 states, pharmacy network, cold-chain delivery, labs, and MSO and friendly-PC structure as every other treatment category, with medication billed at wholesale and 0% markup.
Reviewed September 11, 2026 · 7 min read
In short
- Check every peptide against FDA's current compounding lists before it goes on the menu.
- Each patient needs a provider evaluation and a prescription filled by a licensed pharmacy.
- Leaving FDA's Category 2 list does not make a peptide approved or listed for compounding.
- Injectable peptides need cold-chain shipping, and claims must stay inside FDA and FTC rules.
- On Tessic Health, peptide programs run on the same providers, pharmacy, and structure as every category.
On this page
Why peptides need an extra step
Peptides fall into two groups. Some are FDA-approved drugs, sold under a brand name with a label that says what they treat; the GLP-1 medications are the best-known example. Most of the peptides that wellness and longevity brands talk about are not approved drugs, so patients can get them only as compounded medications, prepared by a pharmacy for an individual prescription.
Compounding has its own federal rules. A 503A pharmacy may compound from a bulk drug substance only if that substance is part of an FDA-approved drug, has a USP monograph (an official quality standard), or appears on FDA's 503A bulks list. While FDA reviews substances nominated for that list, it sorts them into interim categories: Category 1 substances can be compounded during the review, and Category 2 substances are ones FDA has flagged for significant safety concerns.
That is why a peptide menu is a legal question before it is a marketing one. A brand can find strong demand for a peptide that no pharmacy may lawfully compound, and a pharmacy that fills it anyway puts the brand's providers and name at risk.
Start here
Do I need a medical license to start a telehealth company?
No. Licensed clinicians own the medical practice and the founder's company owns the business. Here is exactly who needs which license, and how the two companies fit together.
Read the guideWhat changed for peptides in 2026
Three FDA events matter for any peptide menu. None of them has made a compounded peptide an approved drug.
| When | What happened | What it means for a brand |
|---|---|---|
| April 15, 2026 | FDA removed BPC-157 and eleven other peptides, including TB-500, KPV, MOTS-c, Semax, and Epitalon, from its Category 2 safety list | FDA no longer flags them as significant safety risks. They are not approved drugs, and the move did not add them to the 503A bulks list. |
| July 23 and 24, 2026 | FDA's Pharmacy Compounding Advisory Committee voted to recommend BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax for the 503A bulks list | The votes are advice to FDA. A peptide can be compounded from the bulks list only after FDA formally adds it. |
| Before the end of February 2027 | FDA plans another advisory committee meeting to review more peptides | The rules will keep moving. Re-check the menu after each FDA decision. |
Sources: the FDA advisory committee meeting page and NCPA's summary of the votes. Check FDA's bulk drug substances page for the current status of any peptide before it is prescribed.
The launch sequence
Build the menu against FDA's current lists
Work with a pharmacist and the clinical lead to confirm, peptide by peptide, whether it is an approved drug, compoundable under 503A, or off limits for now. Write down each status and the date it was checked.
Set up the legal structure
The founder's company owns the brand and the business, and a physician-owned professional corporation employs the providers. Do I need a medical license? explains the split and why it applies to peptides the same as any prescription.
Write protocols and intake
Each peptide needs a written protocol: who is a candidate, dose, route, duration, what to monitor, and when to stop. Intake screens for the conditions and medications that rule a patient out, and the protocol decides when labs are needed.
Contract the pharmacy and cold chain
The pharmacy must be licensed in every state it ships into and able to show that each compounded product meets the rules. Many injectable peptides need refrigeration, so shipping needs insulated packaging and a plan for a box that arrives warm.
Build the storefront and subscription
Peptide programs run for weeks or months, so price them as a program with refills on a set schedule. From visits to recurring care covers the billing design that keeps patients enrolled.
Clear claims and ad approvals
Unapproved peptides cannot be marketed as treating any disease, and prescription drug ads on Meta and Google require LegitScript certification. See how to get approved on Meta and Google.
Re-check the rules on a schedule
FDA decisions on peptides are arriving through 2026 and into 2027. Assign someone to watch them and update the menu, protocols, and marketing whenever a status changes.
Claims a peptide brand should never make
Most enforcement against peptide sellers starts with the website. Leave these out of every page, ad, and email:
- "FDA-approved" for any compounded peptide. Compounded drugs are not FDA-approved.
- Claims that a peptide treats, cures, or prevents a disease, when the peptide is not approved for that use.
- "No side effects" or "completely safe." Every drug carries risk, and saying otherwise is a false claim.
- Results stated as guarantees, or patient stories that do not reflect a typical result. The FTC rules in what you can legally say in weight loss marketing apply to longevity claims too.
- Products labeled "research use only" or "not for human consumption" sold to consumers who plan to inject them. The label does not make that sale legal, and FDA has sent warning letters to sellers who tried it.
Build it yourself or launch on Tessic Health
| What the brand needs | Build it yourself | On Tessic Health |
|---|---|---|
| Legal structure | Counsel forms the MSO and PC and drafts the agreements: one to three months | MSO and friendly-PC structure drafted for the client's ownership during setup |
| Providers | Recruit, license, and credential providers state by state | Providers licensed in all 50 states, credentialed under the client's brand |
| Compounding pharmacy | Find and contract a 503A pharmacy licensed in each state you ship into | Contracted pharmacy network, billed at wholesale with 0% markup |
| Cold-chain shipping | Arrange insulated shipping and a policy for warm deliveries | Cold-chain fulfillment on every plan |
| Labs | Contract a lab network and connect results to the chart | Labs included, with results flowing into the patient record |
| Storefront and billing | Build or license checkout, intake, a patient portal, and subscriptions | Branded storefront, patient portal, and subscription and rebill included |
| Time to first patient | Months | Days |
On any platform, what goes on the peptide menu is decided by the clinical lead and the pharmacist against FDA's current rules. Build-it-yourself timelines follow The real cost of launching a telehealth clinic.
COMMON QUESTIONS
What founders ask next.
- Do I need a license to sell peptides?
- The founder does not. Prescription peptides are prescribed by licensed providers, who need a license in each patient's state, and filled by a licensed pharmacy. The founder's company owns the brand and the business through an MSO, and a physician-owned practice makes the medical decisions. Do I need a medical license? covers the details.
- Is BPC-157 legal to compound in 2026?
- Its status is moving. On April 15, 2026, FDA removed BPC-157 from its Category 2 safety list, and on July 23 and 24, 2026, FDA's advisory committee voted to recommend adding it to the 503A bulks list. Those votes are advice. BPC-157 is not an approved drug, and it can be compounded from the bulks list only after FDA formally adds it. Check FDA's current list and the pharmacy's position before prescribing it.
- Can I sell peptides without a prescription?
- Not peptides meant to be injected or taken as drugs. A product sold for use in the human body as a drug has to be an approved drug or a lawfully compounded prescription. Labeling it "for research use only" does not change that when the buyer is a consumer.
- Do peptides need cold-chain shipping?
- Many injectable peptides must stay refrigerated from the pharmacy to the patient, and the pharmacy's handling instructions decide. Plan for insulated packaging, shipping speeds that match each product's stability, and a policy for shipments that arrive warm. Tessic Health includes cold-chain fulfillment on every plan.
- Can a peptide brand advertise on Meta and Google?
- Ads that promote prescription drugs need certification on both platforms: Meta requires active LegitScript certification or its own review and shows these ads only to people 18 and older, and Google requires LegitScript or a similar certification plus its own application. Ads for the brand that name no prescription drug face fewer limits but still follow each platform's health rules. On Tessic Health, the LegitScript application is prepared and filed as part of setup.
- What does a peptide brand cost to launch on Tessic Health?
- The same as any category: Launch is $1,000 a month after an $8,000 one-time setup fee, with $25 per completed consult and medication billed at wholesale with 0% markup. There is no revenue share, and billing is month to month after setup. See what it costs to start.
KEEP READING
The next questions on the list.
- Read the answer
Start here
Do I need a medical license to start a telehealth company?
- Read the answer
Launch by treatment
How do I start an online testosterone (TRT) or hormone therapy practice?
- Read the answer
Launch by treatment
How do I launch a GLP-1 weight loss clinic?
- Read the answer
Advertising
What can I legally say in weight loss marketing?
- Read the answer
Advertising
How do I get my telehealth brand approved for Meta and Google ads?
- Read the answer
Launch planning
What do I need before my telehealth clinic sees its first patient?
SOURCES
- FDA: Bulk drug substances used in compounding
- FDA: Section 503A of the Federal Food, Drug, and Cosmetic Act
- FDA: Pharmacy Compounding Advisory Committee meeting, July 23 and 24, 2026
- NCPA: FDA advisory committee nominates six peptides for pharmacies to compound
- Meta: Drugs and pharmaceuticals ad policy
Reviewed September 11, 2026. Tessic Health guides are general information for founders, not legal advice. Laws, agency guidance, and ad platform policies change; confirm the specifics for your business with health-care counsel. Tessic Health claims restate what tessichealth.com publishes on its pricing, platform, and security pages.